Heart failure in patients admitted to hospital: mortality is still high

European Journal of Internal Medicine

Volumn 13, Issue 5, 2002, Pages 304-310

  Wong, P S ^a   Davidsson, G K ^b   Timeyin, J ^c   Warren, A ^c   Watson, D J ^d   Vincent, R ^d   Davidson, C ^c  

^a CITY HOSPITAL   (United Kingdom)

^b Birch Hill Hospital   (United Kingdom)

^c ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Epidemiology; Heart failure; Mortality; Trends; Vital statistics

Indexed keywords

DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOOP DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; UREA;

ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; HEART FAILURE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERKALEMIA; HYPONATREMIA; MALE; MORTALITY; PRIMARY MEDICAL CARE; PROGNOSIS; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; UNITED KINGDOM; UREA BLOOD LEVEL;

EID: 0036325285     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(02)00086-9     Document Type: Article

References (36)

1. Heart failure in the United States 1970-1985
2. Hospital admissions and deaths due to congestive heart failure in New Zealand, 1988-91
3. Increase in hospital admission rates for heart failure in the Netherlands, 1980-1993
4. Trends in hospitalization and mortality for heart failure in Spain, 1980-1993
5. Survival after the onset of congestive heart failure in Framingham Heart Study subjects
6. Trends in hospitalization for heart failure in Scotland 1980-1990
7. Clinical epidemiology of heart failure: public and private health burden
8. ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials
9. The natural history of congestive heart failure: the Framingham study
10. Clinical events leading to the progression of heart failure: insights from a national database of hospital discharges
11. A survey of heart failure in general practice
12. A national survey of heart failure in French hospitals
13. Worsening of heart failure during hospital course of an unselected cohort of 2507 patients with myocardial infarction is a factor of poor prognosis: the PRIMA study
14. Survey on heart failure in Italian hospital cardiology units-results of the SEOSI study
15. Hospital and long-term survival of patients with acute pulmonary edema associated with coronary artery disease
16. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II
17. Mortality in heart failure: clinical variables of prognostic value
18. Prognostic factors in acute pulmonary edema
19. Predictors of prognosis in severe chronic heart failure
20. Prognostic value of hyponatremia in patients with severe chronic heart failure
21. A new casemix adjustment index for hospital mortality among patients with congestive heart failure
22. Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms
23. The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure
24. Heart failure in a district general hospital
25. Changing patterns of investigation and treatment of cardiac failure in hospital
26. Prevalence, aetiology and management of heart failure in general practice
27. Poles apart, but are they the same? A comparative study of Australian and Scottish patients with chronic heart failure
28. European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF)
29. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
30. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
31. An evaluation of the cost of heart failure to the National Health Service in the UK
32. Health economic consequences of the pharmacological treatment of heart failure